• SPX
  • 5969.34
  • 0.35 %
  • 20.6299
  • DJI
  • 44296.51
  • 0.97 %
  • 426.1602
  • N225
  • 38283.85
  • 0.68 %
  • 257.6797
  • FTSE
  • 8262.08
  • 1.38 %
  • 112.8101
  • IXIC
  • 19003.65
  • 0.16 %
  • 31.2305
Gelesis Holdings, Inc. (GLS) Stock Price, News & Analysis

Gelesis Holdings, Inc. (GLS) Stock Price, News & Analysis

Currency in USD Disclaimer

NA

NA

NA

Day's range
$0.15
Day's range
$0.16
50-day range
$0.011
Day's range
$0.2872
  • Country: US
  • ISIN: N/A
52 wk range
$0.01
Day's range
$5.67
Notice: This company has been marked as potentially delisted and may not be actively trading.


We are preparing, please wait

Analyst Ratings

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

Stock Score/grades

The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company

  • Altman Z Score -7.91
  • Piotroski Score 3.00
  • Grade N/A
  • Symbol (GLS)
  • Company Gelesis Holdings, Inc.
  • Price $0.16
  • Changes Percentage (0%)
  • Change -$0
  • Day Low $0.15
  • Day High $0.16
  • Year High $5.67

Gelesis Holdings Inc., a commercial stage biotherapeutics company, developing a biomimicry to treat the genesis of obesity and GI-related chronic diseases. The company also provides PLENITY, an orally administered, non-stimulant, and non-systemic aid for weight management. In addition, it offers a product for obesity and overweight and a pipeline with potential therapies for non-alcoholic fatty liver disease/non-alcoholic steatohepatitis, type 2 diabetes, and GS500 for Functional Constipation. Gelesis Holdings Inc. was incorporated in 2006 and is headquartered in Boston, Massachusetts.

  • Last Earnings
  • Ex-Dividend for 5/16 Dividend
  • Dividend Payable
  • Today N/A
  • Next Earnings (Estimated) 08/14/2023
  • Fiscal Year End N/A

  • Average Stock Price Target $0.00
  • High Stock Price Target $0.00
  • Low Stock Price Target $0.00
  • Potential Upside/Downside N/A
  • Consensus Rating Neutral
  • Rating Score (0-4) N/A
  • Research Coverage N/A

  • EPS (Most Recent Fiscal Year) -$1.30
  • Trailing P/E Ratio -0.122
  • Forward P/E Ratio -0.122
  • P/E Growth -0.122
  • Net Income $-55,780,000

Income Statement

Quarterly

Annual

Latest News of GLS

The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.

Enter your phone number to get Breaking News Updates

Stay ahead with instant updates! Enter your phone number for breaking news alerts, ensuring you're always in the know with the latest developments.


We are preparing, please wait

Gelesis Holdings, Inc. Frequently Asked Questions

  • What is the Gelesis Holdings, Inc. stock price today?

    Today's price of Gelesis Holdings, Inc. is $0.16 — it has decreased by 0% in the past 24 hours. Watch Gelesis Holdings, Inc. stock price performance more closely on the chart.

  • Does Gelesis Holdings, Inc. release reports?

    Yes, you can track Gelesis Holdings, Inc.'s financials in yearly and quarterly reports directly on Stocks.News.

  • What is the Gelesis Holdings, Inc. stock forecast?

    Watch the Gelesis Holdings, Inc. chart and read a more detailed Gelesis Holdings, Inc. stock forecast to see what analysts suggest you do with its shares.

  • What is Gelesis Holdings, Inc. stock ticker?

    The stock ticker can vary on the respective exchange. For instance, on NYSE, exchange stock trades by Gelesis Holdings, Inc. stock ticker.

  • How to buy Gelesis Holdings, Inc. stocks?

    Like other stocks, GLS shares are sold on stock exchanges such as NYSE. The best way to obtain them is through an online stock broker. Open an account, follow the broker's steps, and start trading.

  • What is Gelesis Holdings, Inc.'s EBITDA?

    Gelesis Holdings, Inc. measures a company's operating performance, and its growth indicates efficiency improvements. Access more stats in Gelesis Holdings, Inc.’s financial statements.

  • What is the Gelesis Holdings, Inc.'s net income ratio for the financial year 2022?

    The net income ratio for the financial year 2022 is -2.1647844142, which equates to approximately -216.48%. This ratio indicates the percentage of net income generated from total revenue and serves as a key measure of a company’s profitability.

  • Should I invest in Gelesis Holdings, Inc. stocks?

    Investing in stocks requires thorough research. Carefully examine all available data, including Gelesis Holdings, Inc.'s financials relevant news, and technical analysis. Gelesis Holdings, Inc.'s technical analysis shows a “buy” rating today and a one-week “buy” rating. Since market conditions can change, it’s wise to look at longer-term trends — the one-month rating for Gelesis Holdings, Inc. stock currently indicates a “sell” signal. For more insights, review Gelesis Holdings, Inc.’s technical analysis.

  • A revenue figure for Gelesis Holdings, Inc. for its last quarter?

    Gelesis Holdings, Inc. published it's last quarterly revenues at $1.11 M.

Portfolio Sync Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED
Portfolio Sync Solutions
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.